Preclinical Validation of First in Man Endovascular Brain Machine Interface Device
Preclinical Validation of First in Man Endovascular Brain Machine Interface Device
批准号:
nhmrc : GNT1138110
负责人:
Dr Nicholas Opie
金额:
$87.0万
依托单位国家:
澳大利亚
项目类别:
Development Grants
财政年份:
2018
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2018-01-01 至 --
中文摘要
继2016年影响因子排名第四的期刊《自然生物技术》(Nature Biotechnology)发表并得到美国总统的公开认可后,支架技术得到了公众的广泛关注。该计划现在寻求进行临床前验证计划,以满足FDA提供研究器械豁免(IDE)的要求。
英文摘要
The stentrode technology has been given significant public attention, following publication in the fourth highest impact factor journal 'Nature Biotechnology' and a public statement of endorsement by the President of the United States in 2016. The program now seeks to conduct a preclinical validation program to satisfy the FDA in its requirements to provide Investigational Device Exemption (IDE).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Preclinical Validation of First in Man Endovascular Brain Machine Interface Device
-
批准号:nhmrc : 1138110
-
项目类别:Development Grants
-
资助金额:$58.82万
-
财政年份:2018
-
负责人:Dr Nicholas Opie
-
依托单位:
Developing a Prototype of a Next Generation Brain Computer Interface
-
批准号:nhmrc : 1075117
-
项目类别:Development Grants
-
资助金额:$55.84万
-
财政年份:2014
-
负责人:Dr Nicholas Opie
-
依托单位:
Minimally-Invasive Brain Machine Interface for Robotic Limb Control
-
批准号:nhmrc : GNT1062532
-
项目类别:Project Grants
-
资助金额:$165.17万
-
财政年份:2014
-
负责人:Dr Nicholas Opie
-
依托单位:
海外基金